Medicine & Health News

TAU study finds that brain function can influence vaccine effectiveness

A new study by Tel Aviv University (TAU), the Technion, and Tel Aviv Medical Center (Ichilov) provides the first evidence in humans that brain activity associated with the expectation of reward has a measurable effect on the body’s response to a specific vaccine. The study was conducted through a collaboration between two research groups: the… Read More

Gene therapy developed by TAU may enable effective treatment for ALS

Researchers at Tel Aviv University (TAU) led a large-scale international study that has identified a molecular mechanism playing a key role in ALS, a fatal degenerative disease, and were able to neutralize it through gene therapy. When they added a specific RNA molecule to human cells and animal models for ALS, the nerve cells stopped… Read More

Novel gene therapy for hereditary hearing loss developed at TAU

Scientists from Tel Aviv University (TAU) have introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. According to the researchers, the treatment constitutes an improvement over existing strategies, demonstrating enhanced efficiency and holding promise for treating a wide range of mutations that cause hearing loss. The study… Read More

TAU researchers discover mechanism that increases myelin production in the brain

Researchers from Tel Aviv University (TAU) have discovered a biological mechanism that boosts the production of myelin, the fatty substance that insulates nerve fibers (axons) and enables rapid, efficient transmission of electrical signals between neurons in the brain and the body. Their findings may serve as the basis for developing innovative treatments for severe neurological… Read More

Children’s health depends on amount of fat in the liver, TAU study reveals

A new study from Tel Aviv University (TAU) and the Dana Dwek Children’s Hospital in Tel Aviv has shown that disease can be prevented in children with obesity by maintaining a low percentage of fat in the liver. The researchers used innovative methods to examine 31 Israeli children with obesity in an attempt to understand… Read More

TAU develops effective therapy without side effects for inflammatory bowel diseases

Researchers at Tel Aviv University (TAU) have developed a new approach for using locked nucleic acids (LNAs), a particularly stable type of RNA, to treat inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. Their findings indicated improvement in all markers of systemic inflammation with no side effects. According to the researchers, this innovative… Read More